Clinical Trials Logo

Bunion clinical trials

View clinical trials related to Bunion.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03257540 Terminated - Hallux Valgus Clinical Trials

Early Weight-Bearing After Lapidus Arthrodesis

Start date: October 31, 2017
Phase:
Study type: Observational

The goal of this research study is to determine if union rates are affected by early weight-bearing after Lapidus Arthrodesis using the Phantomâ„¢ Intramedullary Nail. The study hypothesis is that the union rate for those who undergo a Lapidus Arthrodesis procedure with the Phantomâ„¢ Intramedullary Nail and participate in an early weight-bearing protocol will be non-inferior to union rates previously published for this procedure.

NCT ID: NCT02499575 Terminated - Hallux Rigidus Clinical Trials

Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures

Start date: July 2015
Phase: N/A
Study type: Interventional

Exparel is an FDA-approved local anesthetic (bupivacaine), in a long-release formulation. In this study the investigators plan to determine the ability of Exparel to control post-operative pain in common first metatarsophalangeal (MTP) joint procedures (bunion surgery, 1st MTP fusion, and cheilectomy).

NCT ID: NCT02074748 Terminated - Hallux Valgus Clinical Trials

Measurement of Arch Motion After Bunion Surgery

Start date: February 2014
Phase:
Study type: Observational

This study is an observational "change from baseline" outcome measures design. Data is collected for the sake of evaluating treatment (fusion surgery) performed as standard medical care, but the investigator does not assign specific interventions to any participants in this study.

NCT ID: NCT01133639 Terminated - Bunion Clinical Trials

Ketorolac Effects on Post-operative Pain and Bone Healing

Start date: May 2010
Phase: N/A
Study type: Interventional

This will be a randomized double-blind placebo-controlled clinical trial that will accept all eligible consecutive patients undergoing elective Kalish bunionectomies. Patients will be randomized into either receiving ketorolac (30 mg IV dose intra-operatively followed by 10 mg orally every 8 hours for five days) plus standard of care or placebo plus standard of care. The purpose of this study is to evaluate the effects of ketorolac plus standard of care on post-operative pain control and radiographic osseous healing. Patients will be assessed for pain via a validated pain questionnaire and for delayed unions via a radiographic scoring system shown to have both high inter- and intra-observer reliability by a blinded board certified radiologist. Additional outcomes of bunionectomy procedures will also be evaluated including adverse events and time to regular shoe gear and activities.